Establishment of novel cholangiocarcinoma cell lines with ARID1A deficiency and preclinical validation of synthetic lethality therapiesSunisa Prasopporn(Siriraj Hospital), Siwanon Jirawatnotai(Siriraj Hospital)Scientific ReportsNovember 18, 202510.1038/s41598-025-24420-xCited by 1SaveCiteExport RISWatch citationsRelated PapersCombining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma|Frontiers in Oncology|2022|12